Study of the Apatinib Combine With POF Versus POF in Gastric Cancer

NCT04121039 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

116

Enrollment

OTHER_GOV

Sponsor class

Conditions

Gastric Adenocarcinoma
Advanced Cancer

Interventions

DRUG: Apatinib
DRUG: POF

Sponsor

Fujian Cancer Hospital